RSCM
WST icon

Rock Springs Capital Management’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.2M Sell
51,030
-9,220
-15% -$2.02M 0.7% 50
2025
Q1
$13.5M Sell
60,250
-108,500
-64% -$24.3M 0.77% 46
2024
Q4
$55.3M Buy
168,750
+1,000
+0.6% +$328K 2.1% 14
2024
Q3
$50.4M Buy
167,750
+22,250
+15% +$6.68M 1.64% 20
2024
Q2
$47.9M Buy
145,500
+8,250
+6% +$2.72M 1.44% 26
2024
Q1
$54.3M Hold
137,250
1.38% 25
2023
Q4
$48.3M Sell
137,250
-64,750
-32% -$22.8M 1.19% 28
2023
Q3
$75.8M Hold
202,000
2.03% 14
2023
Q2
$77.3M Hold
202,000
1.84% 16
2023
Q1
$70M Buy
202,000
+16,500
+9% +$5.72M 1.67% 19
2022
Q4
$43.7M Buy
185,500
+5,000
+3% +$1.18M 1.05% 36
2022
Q3
$44.4M Buy
180,500
+69,500
+63% +$17.1M 1.15% 28
2022
Q2
$33.6M Buy
111,000
+41,750
+60% +$12.6M 0.98% 35
2022
Q1
$28.4M Buy
69,250
+23,750
+52% +$9.75M 0.72% 46
2021
Q4
$21.3M Buy
45,500
+15,500
+52% +$7.27M 0.49% 63
2021
Q3
$12.7M Buy
30,000
+1,500
+5% +$637K 0.27% 95
2021
Q2
$10.2M Hold
28,500
0.2% 112
2021
Q1
$8.03M Hold
28,500
0.18% 123
2020
Q4
$8.07M Hold
28,500
0.17% 120
2020
Q3
$7.84M Sell
28,500
-42,500
-60% -$11.7M 0.2% 112
2020
Q2
$16.1M Hold
71,000
0.44% 76
2020
Q1
$10.8M Sell
71,000
-81,500
-53% -$12.4M 0.45% 72
2019
Q4
$22.9M Hold
152,500
0.72% 53
2019
Q3
$21.6M Buy
152,500
+15,000
+11% +$2.13M 0.86% 42
2019
Q2
$17.2M Buy
137,500
+12,500
+10% +$1.56M 0.62% 57
2019
Q1
$13.8M Sell
125,000
-35,000
-22% -$3.86M 0.53% 62
2018
Q4
$15.7M Hold
160,000
0.74% 40
2018
Q3
$19.8M Hold
160,000
0.72% 48
2018
Q2
$15.9M Buy
+160,000
New +$15.9M 0.61% 60